Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Scaling SARS-CoV-2 Wastewater Concentrations to Population Estimates of Infection

View ORCID ProfileEdward H. Kaplan, View ORCID ProfileAlessandro Zulli, Marcela Sanchez, View ORCID ProfileJordan Peccia
doi: https://doi.org/10.1101/2021.07.15.21260583
Edward H. Kaplan
aYale School of Management, Yale University, New Haven, CT 06520, USA
bYale School of Public Health, Yale University, New Haven, CT 06520, USA
cDepartment of Chemical and Environmental Engineering, School of Engineering and Applied Science, Yale University, New Haven, CT 06520, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Edward H. Kaplan
Alessandro Zulli
cDepartment of Chemical and Environmental Engineering, School of Engineering and Applied Science, Yale University, New Haven, CT 06520, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alessandro Zulli
Marcela Sanchez
cDepartment of Chemical and Environmental Engineering, School of Engineering and Applied Science, Yale University, New Haven, CT 06520, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jordan Peccia
cDepartment of Chemical and Environmental Engineering, School of Engineering and Applied Science, Yale University, New Haven, CT 06520, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jordan Peccia
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Monitoring the progression of SARS‐CoV‐2 outbreaks requires accurate estimates of infection rates. Estimation methods based on observed cases are biased due to changes in testing over time. Here we report an approach based upon scaling daily concentrations of SARS‐CoV‐2 RNA in wastewater to infections that produces representative estimates due to the consistent population contribution of fecal material to the sewage collection system.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Kaplan: support from Yale School of Management faculty research fund Zulli, Sanchez, Peccia: pilot grant from the Yale University COVID-19 Research Resource Fund

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

No human subjects involved and hence no IRB; only SARS-CoV-2 RNA concentrations measured in sludge from wastewater treatment plant and COVID-19 tests/case counts used in study.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Author contact information: edward.kaplan{at}yale.edu

  • alessandro.zulli{at}yale.edu

  • marcela.sanchez{at}yale.edu

  • jordan.peccia{at}yale.edu

Data Availability

All data used in study included as supplemental information.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted July 19, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Scaling SARS-CoV-2 Wastewater Concentrations to Population Estimates of Infection
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Scaling SARS-CoV-2 Wastewater Concentrations to Population Estimates of Infection
Edward H. Kaplan, Alessandro Zulli, Marcela Sanchez, Jordan Peccia
medRxiv 2021.07.15.21260583; doi: https://doi.org/10.1101/2021.07.15.21260583
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Scaling SARS-CoV-2 Wastewater Concentrations to Population Estimates of Infection
Edward H. Kaplan, Alessandro Zulli, Marcela Sanchez, Jordan Peccia
medRxiv 2021.07.15.21260583; doi: https://doi.org/10.1101/2021.07.15.21260583

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)